Search - tctmd.com

Displaying 221 - 240 of 241

Sort: Relevancy | Date

Presentation TCT 2016

Debate: Surgery, Septal Ablation or Medical Therapy for Obstructive HCM Not so Fast: Try Optimizing Medical Therapy First!

Presenter: George S. Hanzel, Antoine Lafont, Michael A. Fifer

October 30, 2016

Presentation TCT 2016

Novel Approaches for Septal Ablation: Beyond Alcohol

Presenter: Srihari S. Naidu, Paul Sorajja

October 30, 2016

Presentation TCT 2016

Alcohol Septal Ablation of Ventricular Tachycardia

Presenter: Srihari S. Naidu, Paul Sorajja, George D. Dangas

October 30, 2016

Presentation TCT 2016

An Alcohol Septal Ablation Case I Regret

Presenter: Srihari S. Naidu, Paul Sorajja

October 30, 2016

Presentation TCT 2016

My Best Alcohol Septal Ablation Case

Presenter: Srihari S. Naidu, Paul Sorajja, George S. Hanzel

October 30, 2016

Presentation TCT 2016

Good and Not So Good Cases to Consider for Alcohol Septal Ablation

Presenter: Srihari S. Naidu, Paul Sorajja, John S. Douglas Jr

October 30, 2016

Presentation TCT 2016

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro Pacing

Presenter: Bernard J. Gersh, Harry Rakowski, Michael A. Fifer

October 30, 2016

Presentation TCT 2016

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro ICD!

Presenter: Bernard J. Gersh, Harry Rakowski, George S. Hanzel

October 30, 2016

Presentation TCT 2016

When Is Pacing Needed in HCM Outside Invasive Management Settings

Presenter: Bernard J. Gersh, Harry Rakowski

October 30, 2016

Presentation TCT 2016

Medical Management of Non-Obstructive HCM: When and Which Medications?

Presenter: Bernard J. Gersh, Harry Rakowski, John S. Douglas Jr

October 30, 2016

Presentation TCT 2016

Genetic Testing in Hypertrophic Cardiomyopathy: Role in Prognostication and Screening

Presenter: Howard C. Herrmann, Sherif F. Nagueh, Robert Roberts

October 30, 2016

Presentation TCT 2016

Cardiac Catheterization Is Essential for Hemodynamic Assessment

Presenter: Howard C. Herrmann, Sherif F. Nagueh

October 30, 2016

Presentation TCT 2016

Cardiac MR for Diagnosis and Guiding Management of HCM

Presenter: Howard C. Herrmann, Sherif F. Nagueh, Andrew E. Arai

October 30, 2016

Presentation TCT 2016

Echocardiography Essentials for Comprehensive Evaluation of HCM

Presenter: Howard C. Herrmann, Sherif F. Nagueh

October 30, 2016

Presentation TCT 2016

LV Volume Reduction in Post-AMI, Ischemic Heart Failure Patients

Presenter: Oscar A. Mendiz, Giora Weisz, Horst Sievert

October 30, 2016

News Industry News

NanoCor Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) for Carfostin®

April 20, 2016

News Industry News

Boston Scientific Announces CE Mark For MRI Compatible Labeling For ICD And CRT-D Systems

August 24, 2015

News Industry News

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

June 16, 2015

News Industry News

Juventas Therapeutics Presents New 12-Month Data Demonstrating Single Administration of JVS-100 Improves Cardiac and Clinical Status in Patients with Severe Ischemic Heart Failure One Year After Treat

May 26, 2015

News Conference News ACC 2014

Intramyocardial Injection of Stem Cells Shows Promise for Severe Ischemic Heart Failure

Yael L. Maxwell

March 31, 2014

Advertisement

Debate: Surgery, Septal Ablation or Medical Therapy for Obstructive HCM Not so Fast: Try Optimizing Medical Therapy First!

Novel Approaches for Septal Ablation: Beyond Alcohol

Alcohol Septal Ablation of Ventricular Tachycardia

An Alcohol Septal Ablation Case I Regret

My Best Alcohol Septal Ablation Case

Good and Not So Good Cases to Consider for Alcohol Septal Ablation

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro Pacing

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro ICD!

When Is Pacing Needed in HCM Outside Invasive Management Settings

Medical Management of Non-Obstructive HCM: When and Which Medications?

Genetic Testing in Hypertrophic Cardiomyopathy: Role in Prognostication and Screening

Cardiac Catheterization Is Essential for Hemodynamic Assessment

Cardiac MR for Diagnosis and Guiding Management of HCM

Echocardiography Essentials for Comprehensive Evaluation of HCM

LV Volume Reduction in Post-AMI, Ischemic Heart Failure Patients

NanoCor Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) for Carfostin®

Boston Scientific Announces CE Mark For MRI Compatible Labeling For ICD And CRT-D Systems

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

Juventas Therapeutics Presents New 12-Month Data Demonstrating Single Administration of JVS-100 Improves Cardiac and Clinical Status in Patients with Severe Ischemic Heart Failure One Year After Treat

Intramyocardial Injection of Stem Cells Shows Promise for Severe Ischemic Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content